Cargando…
Choroidal thickness changes in non-treated acute and ranibizumab-treated chronic central serous chorioretinopathy
To evaluate the changes in subfoveal retinal, and choroidal thicknesses (CT) in the non-treated acute and the ranibizumab-treated chronic central serous chorioretinopathy (CSCR) patients. This retrospective study included 32 eyes of 32 consecutive patients with CSCR. There were 12 patients who prese...
Autores principales: | Yumusak, Erhan, Gokcinar, Nesrin Buyuktortop, Ornek, Kemal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221658/ https://www.ncbi.nlm.nih.gov/pubmed/30412084 http://dx.doi.org/10.1097/MD.0000000000012885 |
Ejemplares similares
-
Long-term Results of Ranibizumab, Dexamethasone Implant, and Triamcinolone in Macular Edema due to Branch Retinal Vein Occlusion
por: Dikel, Nevin Hande, et al.
Publicado: (2019) -
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients: Corneal endothelium after dexamethasone implant injection
por: Güler, Hatice Ayhan, et al.
Publicado: (2018) -
Choroidal thickness in older patients with central serous chorioretinopathy
por: Regatieri, Caio V., et al.
Publicado: (2016) -
Evaluation of Choroidal Layer Thickness in Central Serous Chorioretinopathy
por: Hanumunthadu, Daren, et al.
Publicado: (2019) -
Comparison of Perioperative Ranibizumab Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery
por: Yumuşak, Erhan, et al.
Publicado: (2016)